United States · FDA National Drug Code directory

LICART

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71858-0305_4e7d176c-1593-6214-e063-6394a90a4042
Product NDC
71858-0305
Form
SYSTEM
Composition / generic term
diclofenac epolamine
Labeler
IBSA Pharma Inc.
Marketing category
NDA
Marketing start / end (source format)
20200901
Source listing expiry
20271231

Source-listed ingredients

  • DICLOFENAC EPOLAMINE — .013 g/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 POUCH in 1 CARTON (71858-0305-2) / 2 SYSTEM in 1 POUCH (71858-0305-1) · 71858-0305-2
  • 3 POUCH in 1 CARTON (71858-0305-5) / 5 SYSTEM in 1 POUCH (71858-0305-4) · 71858-0305-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
LICART — United States | Molindra Medicines